Lynn Heltemes-Harris

985 total citations
23 papers, 695 citations indexed

About

Lynn Heltemes-Harris is a scholar working on Immunology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lynn Heltemes-Harris has authored 23 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 8 papers in Oncology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lynn Heltemes-Harris's work include Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (10 papers) and CAR-T cell therapy research (7 papers). Lynn Heltemes-Harris is often cited by papers focused on Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (10 papers) and CAR-T cell therapy research (7 papers). Lynn Heltemes-Harris collaborates with scholars based in United States, Netherlands and Croatia. Lynn Heltemes-Harris's co-authors include Michael A. Farrar, Tim Manser, Mark Willette, Laura B. Ramsey, Steven M. Kornblau, Michael Y. Gerner, Brian T. Fife, Matthew F. Mescher, Todd P. Knutson and Xiaohe Liu and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Blood.

In The Last Decade

Lynn Heltemes-Harris

22 papers receiving 689 citations

Peers

Countries citing papers authored by Lynn Heltemes-Harris

Since Specialization

Citations

This map shows the geographic impact of Lynn Heltemes-Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Heltemes-Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Heltemes-Harris more than expected).

Fields of papers citing papers by Lynn Heltemes-Harris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Heltemes-Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Heltemes-Harris. The network helps show where Lynn Heltemes-Harris may publish in the future.

Co-authorship network of co-authors of Lynn Heltemes-Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Heltemes-Harris. A scholar is included among the top collaborators of Lynn Heltemes-Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Heltemes-Harris. Lynn Heltemes-Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Leukemia escapes immunity by imposing a type 1 regulatory program on neoantigen-specific CD4+ T cells 2025 ·Blood ·(unknown), (unknown), (unknown), (unknown), Lynn Heltemes-Harris, Todd P. Knutson, Yinjie Qiu, (unknown), Beau R. Webber, Veronika Bachanová, Michael A. Farrar, Sean Tracy	0
2	Nuclear corepressors NCOR1/NCOR2 regulate B cell development, maintain genomic integrity and prevent transformation 2022 ·Nature Immunology ·(unknown), Todd P. Knutson, Sarah A. Munro, Jeffrey T. Miller, Lynn Heltemes-Harris, Charles G. Mullighan, Kristen Jepsen, Michael A. Farrar	8
3	Single-cell analysis identifies dynamic gene expression networks that govern B cell development and transformation 2021 ·Nature Communications ·(unknown), Sarah A. Munro, Todd P. Knutson, Rebecca S. LaRue, Lynn Heltemes-Harris, Michael A. Farrar	47
4	Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia 2021 ·Oncogene ·Lynn Heltemes-Harris, (unknown), Rebecca S. LaRue, Sarah A. Munro, Rendong Yang, Christine Henzler, Timothy K. Starr, Aaron L. Sarver, Steven M. Kornblau, Michael A. Farrar	13
5	B-1a cells acquire their unique characteristics by bypassing the pre-BCR selection stage 2019 ·Nature Communications ·(unknown), Susannah L. Hewitt, Lynn Heltemes-Harris, Malay Mandal, Kristen Johnson, Klaus Rajewsky, Sergei B. Koralov, Marcus R. Clark, Michael A. Farrar, Jane A. Skok	49
6	Sleeping Beauty Screen Identifies RREB1 and Other Genetic Drivers in Human B-cell Lymphoma 2018 ·Molecular Cancer Research ·Eric P. Rahrmann, Natalie K. Wolf, George M. Otto, Lynn Heltemes-Harris, Laura B. Ramsey, Jingmin Shu, Rebecca S. LaRue, (unknown), Susan K. Rathe, Timothy K. Starr, Michael A. Farrar, Branden S. Moriarity, David A. Largaespada	14
7	Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival 2017 ·Nature Immunology ·(unknown), Lynn Heltemes-Harris, Mark Willette, Christine Henzler, Seth Frietze, Rendong Yang, Hilde Schjerven, Kevin A.T. Silverstein, Laura B. Ramsey, (unknown), Andrew D. Wells, Roland P. Kuiper, Blanca Scheijen, Frank N. van Leeuwen, Markus Müschen, Steven M. Kornblau, Michael A. Farrar	63
8	Sleeping Beauty transposon screen identifies signaling modules that cooperate with STAT5 activation to induce B-cell acute lymphoblastic leukemia 2015 ·Oncogene ·Lynn Heltemes-Harris, Jon D. Larson, Timothy K. Starr, (unknown), Aaron L. Sarver, David A. Largaespada, Michael A. Farrar	22
9	Cutting Edge: IL-12 and Type I IFN Differentially Program CD8 T Cells for Programmed Death 1 Re-expression Levels and Tumor Control 2013 ·The Journal of Immunology ·Michael Y. Gerner, Lynn Heltemes-Harris, Brian T. Fife, Matthew F. Mescher	60
10	The role of STAT5 in lymphocyte development and transformation 2012 ·Current Opinion in Immunology ·Lynn Heltemes-Harris, Michael A. Farrar	46
11	Constitutively Active STAT5 Constructs 2012 ·Methods in molecular biology ·Lynn Heltemes-Harris, Michael A. Farrar	1
12	The role of STAT5 in the development, function, and transformation of B and T lymphocytes 2011 ·Annals of the New York Academy of Sciences ·Lynn Heltemes-Harris, Mark Willette, Kieng B. Vang, Michael A. Farrar	30
13	Activation-induced deaminase-mediated class switch recombination is blocked by anti-IgM signaling in a phosphatidylinositol 3-kinase-dependent fashion 2007 ·Molecular Immunology ·Lynn Heltemes-Harris, Patricia J. Gearhart, Paritosh Ghosh, Dan L. Longo	14
14	An antibody VH gene that promotes marginal zone B cell development and heavy chain allelic inclusion 2005 ·International Immunology ·Lynn Heltemes-Harris, Xiaohe Liu, Tim Manser	9
15	Progressive Surface B Cell Antigen Receptor Down-Regulation Accompanies Efficient Development of Antinuclear Antigen B Cells to Mature, Follicular Phenotype 2004 ·The Journal of Immunology ·Lynn Heltemes-Harris, Xiaohe Liu, Tim Manser	37
16	The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells 2002 ·Cancer Gene Therapy ·Lynn Heltemes-Harris, Christy R. Hagan, (unknown), Rekha G. Panchal, Jun Guo, Charles J. Link	16
17	Dominant, Hierarchical Induction of Peripheral Tolerance during Foreign Antigen-Driven B Cell Development 2002 ·Immunity ·(unknown), Lynn Heltemes-Harris, Tim Manser	46
18	Predominance of a novel splenic B cell population in mice expressing a transgene that encodes multireactive antibodies: support for additional heterogeneity of the B cell compartment 2001 ·International Immunology ·(unknown), (unknown), Lynn Heltemes-Harris, Xianghua Zhang, Lawrence J. Wysocki, Tim Manser	8
19	Isolation and mapping of two chicken POU family genes and the identification of a syntenic group with human and mouse 1997 ·Animal Genetics ·Lynn Heltemes-Harris, Christopher K. Tuggle, Susan J. Lamont	5
20	Octamer function in the chicken lambda immunoglobulin light chain promoter 1997 ·Immunogenetics ·Lynn Heltemes-Harris, Christopher K. Tuggle, S.J. Lamont	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact